Imagine a world where MS management is no longer a one-size-fits-all approach, but rather a personalized and tailored experience. In this third episode, we unveil how the integration of advanced technologies is paving the way for a new era of MS care.
In this episode, Prof. Dr. Gavin Giovannoni from the Queen Mary University of London and Blizard Institute, along with PD Dr. Benjamin Friedrich, Co-Founder & Chief Medical Officer of Temedica and board certified neuroradiologist, discuss the following key topics:
Current MS Research Challenges: Understanding the pathophysiology of MS; addressing the complexities in diagnosis and treatment taking into account the heterogeneity of the disease.
Unlocking the power of RWD: Harnessing data from diverse sources like electronic health records and mobile devices to drive comprehensive insights and ultimately optimize treatment approaches (examples: MSBase registry and the Brisa App).
Impact of AI: Utilizing AI for predictive analytics in disease progression and treatment responses, improving imaging and diagnostics for earlier detection, and exploring future trends in advanced predictive models and real-time patient monitoring.
Ethical Considerations: Ensuring data privacy and security, addressing biases in AI algorithms, and emphasizing the augmentation of clinician expertise with technology.
Explore the episode now to discover how AI and RWD are reshaping the future of MS care.